Luis Souhami is an expert in Radiotherapy at McGill University Health Centre (Canada). As of September 2026, ScienceLeadR ranks Luis Souhami in the top 1% of experts worldwide for Urogenital Neoplasms. Luis Souhami has authored 520 publications, the most recent in 2026, and is an investigator in 17 clinical trials. SLR score: 1,511 (community average: 125). How the SLR is computed.

LeadR Profile

1 511 ScienceLeadR Reputation 1511
Network Map

Radiotherapy

Subspecialties: Oncology - Urology - Neurology

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Expert Rankings

Top experts on the MeSH terms this expert works on

Organizations

Career arc: 1987 - 2026

Source: PubMed

McGill University

Publications Synthesis

Sources: PubMed, OpenAlex

Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Simpson Grading and Risk of Recurrence in 4074 Meningioma Patients With Gross Total Resection.
PMID 42765693 — neoplasms, classification, meningioma
Neurosurgery20260
Variation in meningioma recurrence risk estimates across observational cohorts: the influence of calendar time, WHO classifications, geographical settings, and healthcare systems.
PMID 42663731 — classification, meningioma
J Neurooncol20260
"Cumulative incidence of toxicity between 2 and 5 years following SBRT to the prostate and pelvis nodes in patients with high-risk prostate cancer ".
PMID 42435987 — radiation oncology, lymph nodes, incidence, neoplasms, prostate, lymph, prostatic neoplasms, therapeutics
Pract Radiat Oncol20260
Dose escalation with intraoperative radiotherapy in newly diagnosed glioblastoma (INTRAGO-II): an open-label, multicentre, randomised, controlled, phase 3 trial.
PMID 42372746 — radiotherapy, lung, progression-free survival, temozolomide, neoplasms, drug-related side effects and adverse reactions, glioblastoma, therapeutics, infections
Lancet Oncol Top journal20264
The Ki-67 proliferation index and recurrence risk of intracranial meningioma: a multicenter, retrospective cohort study of 5,050 patients.
PMID 41942766 — cohort studies, neurosurgery, meningioma
Acta Neurochir (Wien)20260

Clinical Studies 17

Sources: ClinicalTrials, EU CTIS

Synthesis

Study Chair: 2 Sub-Investigator: 1

By phase:

Phase 3 13
N/A 2
Phase 1/Phase 2 1
Phase 2 1

By status:

Completed 12
Active not recruiting 3
Recruiting 1
Terminated 1

By type:

Interventional 17

By Monocentric/Multicentric:

monocentric 4
multicentric2to4 2
multicentric5to9 0
multicentricup10 11

Main Topics

LeadR Networks

Main global connection map